Detalhe da pesquisa
1.
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): final analysis of a phase III, randomized, double-blind, placebo-controlled study.
Breast Cancer Res Treat
; 197(3): 503-513, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463547
2.
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial.
Gastric Cancer
; 26(1): 123-131, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066725
3.
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).
Haemophilia
; 25(3): 382-391, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016855
4.
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi-centre, non-interventional study.
Haemophilia
; 24(6): 921-929, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295389
5.
Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer.
Eur J Cancer
; 178: 70-81, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410207
6.
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis.
Cancers (Basel)
; 14(20)2022 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291835
7.
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.
J Clin Oncol
; 40(5): 438-448, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890214
8.
Plasma alkylresorcinols as a biomarker of whole-grain food consumption in a large population: results from the WHOLEheart Intervention Study.
Am J Clin Nutr
; 95(1): 204-11, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22170369